YE

Yusuf Erkul

Chief Executive Officer & Cofounder

Kernal Biologics

Kernal Biologics Pipeline

DrugIndicationPhase
In vivo CAR-TBladder cancer, Merkel cell carcinoma, cutaneous squamous cell carcinoma, head and neck cancerPreclinical